Article Excerpt: Digital therapeutics (DTx) startups secured a record-breaking $3.4 billion across 122 deals in 2021, up 133% from the prior year. DTx enables the treatment of chronic conditions at scale and is demonstrating improved patient outcomes in clinical trials, according to CB Insights analysts. This is driving investor interest in the technology’s future. The digital mental health space was growing rapidly even before the COVID-19 pandemic but stress and anxiety brought on by the health crisis have accelerated demand for virtual behavioral health services, including mobile mental health apps.
Full Article: https://tinyurl.com/yckps5dj
Article Source: Fierce Healthcare